Evaluation of medication adherence among Lebanese diabetic patients

Por Lara Mroueh, Dana Ayoub, Maya El-Hajj, Sanaa Awada, Samar Rachidi, Salam Zein, Amal Al-Hajje
Publicado no Pharmacy Practice (2018)

Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2...

Por Giorgino F, Penfornis A, Pechtner V, Gentilella R, Corcos A
Publicado em 2018-05-01

Pharmacokinetic/pharmaco–dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)‐tetrahydrocannabinol challenge tests

Por Guan, Zheng, Klumpers, Linda E., Oyetayo, Olubukayo‐Opeyemi, Heuberger, Jules, van Gerven, Joop M. A., Stevens, Jasper
Publicado no Br J Clin Pharmacol (2016)

Multi-component infusion hepatoprotectors for liver damage

Por E. I. Sas, V. B. Grinevich
Publicado em 2019-05-01

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer

Por Deben, Christophe, Wouters, An, de Beeck, Ken Op, van Den Bossche, Jolien, Jacobs, Julie, Zwaenepoel, Karen, Peeters, Marc, Van Meerbeeck, Jan, Lardon, Filip, Rolfo, Christian, Deschoolmeester, Vanessa, Pauwels, Patrick
Publicado no Oncotarget (2015)

Study of Sodium Valproate's Side Effects in 2 to 15 -Year-Old Children with Epilepsy or Migraine Disorders

Por Omid Yaghini, Jafar Nasiri, Parisa Nasr-Isfahani
Publicado em 2016-08-01

Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study

Por Margulies, Susan S., Kilbaugh, Todd, Sullivan, Sarah, Smith, Colin, Propert, Kathleen, Byro, Melissa, Saliga, Kristen, Costine, Beth A., Duhaime, Ann‐Christine
Publicado no Brain Pathol (2015)

Didanosine Population Pharmacokinetics in West African Human Immunodeficiency Virus-Infected Children Administered Once-Daily Tablets in Relation to Efficacy after One Year of Trea...

Por Hirt, Déborah, Bardin, Christophe, Diagbouga, Serge, Nacro, Boubacar, Hien, Hervé, Zoure, Emmanuelle, Rouet, François, Ouiminga, Adama, Urien, Saik, Foulongne, Vincent, Van De Perre, Philippe, Tréluyer, Jean-Marc, Msellati, Philippe
Publicado em 2009

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

Por Sarno, Stefania, de Moliner, Erika, Ruzzene, Maria, Pagano, Mario A, Battistutta, Roberto, Bain, Jenny, Fabbro, Doriano, Schoepfer, Joseph, Elliott, Matthew, Furet, Pascal, Meggio, Flavio, Zanotti, Giuseppe, Pinna, Lorenzo A
Publicado em 2003

Single dose oral nefopam for acute postoperative pain in adults

Por Kakkar, Manish, Derry, Sheena, Moore, R Andrew, McQuay, Henry J
Publicado em 2009

Modelaje matemático del modelo neurobiológico de las adicciones

Por Miguel Angel Mendoza, Sinuhé Muñoz-Sánchez, Mariana Alvarado-Vargas, Daniel Jiménez Álvarez, Andrea Gallegos
Publicado em 2017-06-01

Integrating substance abuse care with community diabetes care: implications for research and clinical practice

Por Ghitza, Udi E, Wu, Li-Tzy, Tai, Betty
Publicado em 2013

Clinical course and outcomes of type-2 diabetic patients after treatment intensification...

Por Bramlage, Peter, Gitt, Anselm K, Schneider, Steffen, Deeg, Evelin, Tschöpe, Diethelm
Publicado no BMC Cardiovasc Disord (2014)

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability

Por Pastores, Gregory M., Rosenbloom, Barry, Weinreb, Neal, Goker-Alpan, Ozlem, Grabowski, Gregory, Cohn, Gabriel M., Zahrieh, David
Publicado em 2014

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up

Por Ficociello, Linda H., Rosolowsky, Elizabeth T., Niewczas, Monika A., Maselli, Nicholas J., Weinberg, Janice M., Aschengrau, Ann, Eckfeldt, John H., Stanton, Robert C., Galecki, Andrzej T., Doria, Alessandro, Warram, James H., Krolewski, Andrzej S.
Publicado em 2010

FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system

Por Pereira, Felipe V., Arruda, Denise C., Figueiredo, Carlos R., Massaoka, Mariana H., Matsuo, Alisson L., Bueno, Valquiria, Rodrigues, Elaine G.
Publicado em 2013

A data-driven approach to optimized medication dosing: a focus on heparin

Por Ghassemi, Mohammad M., Richter, Stefan E., Eche, Ifeoma M., Chen, Tszyi W., Danziger, John, Celi, Leo A.
Publicado em 2014

Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers...

Por Nations, Kari R., Bursi, Roberta, Dogterom, Peter, Ereshefsky, Larry, Gertsik, Lev, Mant, Tim, Schipper, Jacques
Publicado em 2012

Experience of using an excimer lamp equipped with UVB dose control system in dermatology

Por D. V. Schitz, I. E. Torshina, N. V. Nekrasova, T. M. Busko
Publicado em 2020-04-01

Medication errors: problems and recommendations from a consensus meeting

Por Agrawal, Abha, Aronson, Jeffrey K, Britten, Nicky, Ferner, Robin E, de Smet, Peter A, Fialová, Daniela, Fitzgerald, Richard J, Likić, Robert, Maxwell, Simon R, Meyboom, Ronald H, Minuz, Pietro, Onder, Graziano, Schachter, Michael, Velo, Giampaolo
Publicado em 2009